Cartesian Therapeutics RNAC
NASDAQ RNAC
$7.36 +0.14 (+1.94%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cartesian Therapeutics (RNAC) Interest & Investment Income (2015 - 2026)

Updated

Cartesian Therapeutics' Interest & Investment Income came in at $1.1 million for Q2 2026, down 36.9% from $1.75 million a year earlier but up 7.5% from the prior quarter.

Analysis

Cartesian Therapeutics (RNAC) Interest & Investment Income (2015 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Cartesian Therapeutics reported Interest & Investment Income of $4.95 million, down 43.7% year-over-year; for FY2025, it came in at $6.58 million, down 10.9% from FY2024.

  • Interest & Investment Income carries a five-year compound annual growth rate of 90.8% (FY2020 to FY2025).
  • Going back by year, Interest & Investment Income was $7.39 million in FY2024 (+48.8%), $4.96 million in FY2023 (+139.5%), $2.07 million in FY2022 and $44,000 in FY2021 (-83.1%).
  • The five-year range for quarterly Interest & Investment Income is $9,000 (Q4 2021) to $2.57 million (Q3 2024).
  • Year-over-year, Interest & Investment Income has declined for four consecutive quarters, with growth averaging 25.5% over the last eight quarters.
  • The fastest year-over-year change in Interest & Investment Income over five years came in Q2 2023 (growth of 573.4%), and the weakest in Q1 2026 (a decline of 49.1%).
  • Business Quant data shows RNAC's Interest & Investment Income at $1.03 million (Q1 2026), $1.27 million (Q4 2025) and $1.55 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Cartesian Therapeutics 221.08 Mn 221.08 Mn - 1.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.10 Mn
Mar 31, 2026 1.03 Mn
Dec 31, 2025 1.27 Mn
Sep 30, 2025 1.55 Mn
Jun 30, 2025 1.75 Mn
Mar 31, 2025 2.02 Mn
Dec 31, 2024 2.45 Mn
Sep 30, 2024 2.57 Mn
Jun 30, 2024 1.20 Mn
Mar 31, 2024 1.16 Mn
Dec 31, 2023 940,000.00
Sep 30, 2023 1.30 Mn
Jun 30, 2023 1.39 Mn
Mar 31, 2023 1.33 Mn
Dec 31, 2022 1.14 Mn
Sep 30, 2022 710,000.00
Jun 30, 2022 207,000.00
Mar 31, 2022 15,000.00
Dec 31, 2021 9,000.00
Sep 30, 2021 11,000.00
API Access

Cartesian Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=RNAC&period=max&api_key=YOUR_API_KEY